Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report

Radiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is...

Full description

Bibliographic Details
Main Authors: Ronak Patel, James Hu, Shefali Chopra, Christopher Lee
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Rare Tumors
Online Access:https://doi.org/10.1177/2036361318821763
id doaj-78f5e7c6d8b54dbcbf707809c94d86ed
record_format Article
spelling doaj-78f5e7c6d8b54dbcbf707809c94d86ed2020-11-25T03:38:38ZengSAGE PublishingRare Tumors2036-36132019-01-011110.1177/2036361318821763Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case reportRonak Patel0James Hu1Shefali Chopra2Christopher Lee3Internal Medicine, LAC + USC Medical Center, Glendale, CA, USAMedical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USAPathology, Keck Medical Center, University of Southern California, Los Angeles, CA, USADiagnostic Radiology, Keck Medical Center, University of Southern California, Los Angeles, CA, USARadiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is surgical resection if possible; however, the role of chemotherapy has not been well defined. The patient described herein had a central tumor in the chest wall. Since many of these patients have borderline resectable tumors, the use of neoadjuvant chemotherapy may be helpful to downstage the tumors for possible surgical resection. In this case, doxorubicin plus ifosfamide chemotherapy was employed with a favorable therapeutic effect prior to being resected. To our knowledge this is the first report of greater than 90% necrosis in a patient with radiation-associated undifferentiated/unclassified soft-tissue sarcoma treated with chemotherapy for a borderline resectable mass.https://doi.org/10.1177/2036361318821763
collection DOAJ
language English
format Article
sources DOAJ
author Ronak Patel
James Hu
Shefali Chopra
Christopher Lee
spellingShingle Ronak Patel
James Hu
Shefali Chopra
Christopher Lee
Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
Rare Tumors
author_facet Ronak Patel
James Hu
Shefali Chopra
Christopher Lee
author_sort Ronak Patel
title Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
title_short Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
title_full Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
title_fullStr Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
title_full_unstemmed Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
title_sort neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: a case report
publisher SAGE Publishing
series Rare Tumors
issn 2036-3613
publishDate 2019-01-01
description Radiation-associated sarcomas are rare and aggressive types of sarcomas that can occur after exposure to ionizing radiation. We examine a case of radiation-associated undifferentiated/unclassified soft-tissue sarcoma with primary disease in the chest wall. The optimal treatment of these patients is surgical resection if possible; however, the role of chemotherapy has not been well defined. The patient described herein had a central tumor in the chest wall. Since many of these patients have borderline resectable tumors, the use of neoadjuvant chemotherapy may be helpful to downstage the tumors for possible surgical resection. In this case, doxorubicin plus ifosfamide chemotherapy was employed with a favorable therapeutic effect prior to being resected. To our knowledge this is the first report of greater than 90% necrosis in a patient with radiation-associated undifferentiated/unclassified soft-tissue sarcoma treated with chemotherapy for a borderline resectable mass.
url https://doi.org/10.1177/2036361318821763
work_keys_str_mv AT ronakpatel neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport
AT jameshu neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport
AT shefalichopra neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport
AT christopherlee neoadjuvantchemotherapyforradiationassociatedsofttissuesarcomaacasereport
_version_ 1724541411945086976